SharePoint
A- A A+
Home > Research > Enablers > P.H. Feng Research Centre

​​​

Overview

The Research Centre is named in memory of Professor Feng Pao Hsii (1936–2015), the visionary medical leader who established the Tan Tock Seng Hospital Clinical Research Unit in 1997.

P.H. Feng Research Centre (PHFRC) is located at level 2 of the National Centre for Infectious Diseases (NCID) within the integrated HealthCity Novena community.

The Research Centre offers various facilities such as examination rooms, infusion rooms, beds for inpatient and outpatient studies, a drug storage room, a laboratory specimen processing room; and services such as in-house physician for safety monitoring, study coordinators for project and subject management, research nurses for drug infusion and procedures.


​The centre is staffed with professionals who are Good Clinical Practice (GCP) trained and experienced in conducting early phase clinical trials involving pharmacokinetic, pharmacodynamic evaluations.

The research centre also conducts phase 2 and phase 3 clinical trials and partners with  Academic institutions such as A*STAR, National Skin Centre, Skin Research Institute of Singapore (SRIS), pharmaceutical companies including but not limited to Roche, Bristol-Myers Squibb (BMS), Merck & Co.(MSD), Novartis, Amgen and  AstraZeneca as well as clinical research organization (CRO) such as IQVIA, Paraxel, Icon , Fortrea and Syneos.

The Research Centre was established to consolidate clinical trials within Tan Tock Seng Hospital and facilitate collaborations with academics and industry partners in research. It is designed to conduct high quality clinical trials, enabling patient access to novel therapeutics and innovative technology.

Services

  • Allowing for the conduct clinical research such as:

    • Early phase research requires extensive pharmacokinetic and pharmacodynamic sampling
    • Studies requiring​ post treatment close monitoring
    • Healthy volunteer study
    • Biological specimen processing and storage
    • Investigational Product (IP) storage, preparation, labelling, administration
    • Storage and archival of study documents
    • Regulatory and budget management
    • Medical care of research subjects
    • Subject recruitment and monitoring
    • Adverse event monitoring and reporting
    • Coordinating and preparing for monitoring, audits and inspection.
    • Study communication and coordination
    • Infusion services for investigational drugs, biologics, and cell products

​​Our Facilities

​​



For a complete list of clinical trials in TTSH, please refer to this link​.





















2025/03/17
Last Updated on 17 Mar 2025